In some diseases, such as Hodgkin lymphoma or multiple myeloma, FoxO1 plays its role as a tumor suppressor and neoplasia development is characterized by a lack of FoxO1 activity. This evidence concerns the gene FOXO1 and Hodgkins lymphoma.